Discover 767 paid clinical trials in Elk Grove, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 767
New
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
for
Locally Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Sacramento CA, Aurora CO
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT06211335
Phase1, Recruiting
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Sacramento CA, Dallas TX, San Antonio TX, Houston TX,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase1, Recruiting
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumor
Location: Sacramento CA, Santa Monica CA, Nashville TN,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05785741
Phase1, Phase2, Recruiting
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
for
Metastatic Cancer
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT06389123
Phase1, Recruiting
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
for
Metastatic Non-small Cell Lung Cancer
Location: Sacramento CA, Seattle WA, Houston TX, Nashville TN,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT04410796
Phase2, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)